Work

A phase II pilot efficacy trial of the combination regimen peg asparaginase/peg liposomal doxorubicin/dexamethasone (ODD) in patients with refractory lymphoid malignancies (NCT00837200).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e19502

Authors: Joseph J. Drabick, Ritu Lapsiwala, Giampaolo Talamo, Elliot E Epner, Jeffrey G. Supko, David Claxton, W. Christopher Ehmann, Mary Lander, Michelle St. Pierre, Witold B. Rybka

Institutions: Penn State Cancer Institute, Massachusetts General Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604990138

Cites:

Cited by: 2

Related to: 10